IVC is trading bullishly on announcement that its FDA issues may be nearing an end. Market appears to be pricing in a clean final review by the FDA but stockholders have been fooled before. The company also is in the midst of a strategic change that they hope will result in positive earnings. Management tells a good story but there may not be a positive quarter until 2018. The Company is positioned well for the theme of an aging population but a full realization of potential will not be safely priced in until the FDA is satisfied and management turns the P&L and cash flows positive.
Finally ready for FDA re-inspection.
BRIEF-Invacare says completed 2 milestones required to initiate FDA's re-inspection
For all those that are frustrated in the lack of exposure on INVO Bioscience and the INVOcell, you do know you can help right? Many of you are on Facebook, Twitter, Instagram and other platforms. Why are you not telling your friends, family, etc and sharing the news about this revolutionary life enabling device?
Search Twitter to find the latest news and world events faster. Find popular people, hashtags and photos for any topic you can imagine.
IVC, looks to be overvalued at this price have you guys heard of awe-someSTOCKS. i started receiving their allerts and so far i am happy.
IVC appears to suggest upside opportunity given the performance % (quarter|performance % (q)|performance (quarter)} at 2.20%. Not sure how awesom-eSTOCKS finds all these incredible trade ideas but im happy.
Crush the NASDAQ & NYSE with the Biggest Winners from PennySt0ck101.0rg
Big Gaining, Low-Priced NASDAQ and NYSE Alerts ---> PennyStockl0l.org
X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks May-2016 1,000 Day Parameter 4,338 NYSE Stocks Price Analysis This stock mode of correlation coefficient is 0.4 In other words, the correlation coefficient of the other stocks
Has the FDA decided to run this company out of business?